Biocon shares decline after USFDA issues Form 483 with five observations for Bengaluru unit

The inspection was conducted between April 20 and April 29, 2026 and covered three Biologics manufacturing units, five quality testing laboratories and two warehouses.

Leave a Reply

Your email address will not be published. Required fields are marked *